CC - The Chemours Company

NYSE - NYSE Delayed Price. Currency in USD
13.11
-0.49 (-3.60%)
At close: 4:00PM EDT

13.11 0.00 (0.00%)
After hours: 4:37PM EDT

Stock chart is not supported by your current browser
Previous close13.60
Open13.26
Bid13.27 x 800
Ask13.76 x 3000
Day's range13.12 - 13.67
52-week range7.02 - 25.35
Volume1,582,845
Avg. volume3,292,370
Market cap2.153B
Beta (5Y monthly)2.38
PE ratio (TTM)N/A
EPS (TTM)-0.28
Earnings date30 Jul 2020 - 03 Aug 2020
Forward dividend & yield1.00 (7.08%)
Ex-dividend date14 May 2020
1y target est12.73
  • Associated Press

    Report: Chemical firm Chemours won't face federal charges

    Federal prosecutors have declined to pursue criminal charges against a chemical company that for years discharged compounds with unknown health risks into a North Carolina river, the company disclosed. The U.S. Attorney’s Office and the Environmental Natural Resources Division of the U.S. Justice Department were investigating potential violations of the federal Clean Water Act by The Chemours Co., a spinoff of DuPont that has a plant near Fayetteville, WRAL-TV reported.

  • The Chemours Company (CC) Q1 2020 Earnings Call Transcript
    Motley Fool

    The Chemours Company (CC) Q1 2020 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Chemours Company First quarter Earnings Call. Before we start, I'd like to remind you that comments made on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including the impact of COVID-19 on our business and operations and the other risks and uncertainties described in the documents Chemours has filed with the SEC.

  • Why Chemours Stock Jumped 13% Today
    Motley Fool

    Why Chemours Stock Jumped 13% Today

    Shares of specialty chemical company Chemours (NYSE: CC) jumped nearly 14% as trading opened for the day. Although the company's titanium coatings business did well (sales were up 10% in the segment), its other two divisions (fluoroproducts and chemical solutions) saw year-over-year sales declines.

  • Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1
    Zacks

    Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1

    Decline volumes in the Fluoroproducts unit and lower global average prices across all segments hurt Chemours' (CC) Q1 sales.

  • Chemours (CC) Tops Q1 Earnings Estimates
    Zacks

    Chemours (CC) Tops Q1 Earnings Estimates

    Chemours (CC) delivered earnings and revenue surprises of 39.22% and -2.77%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Why Shares of Chemours Are Soaring Today
    Motley Fool

    Why Shares of Chemours Are Soaring Today

    The company's former parent expects to settle a dispute over retained environmental liabilities.

  • Earnings Preview: Chemours (CC) Q1 Earnings Expected to Decline
    Zacks

    Earnings Preview: Chemours (CC) Q1 Earnings Expected to Decline

    Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Chemours Provides Update in Response to Coronavirus Outbreak
    Zacks

    Chemours Provides Update in Response to Coronavirus Outbreak

    Chemours (CC) is likely to use the $300-million proceeds from borrowings in the future for working capital needs or other general corporate purposes.

  • Are Options Traders Betting on a Big Move in Chemours (CC) Stock?
    Zacks

    Are Options Traders Betting on a Big Move in Chemours (CC) Stock?

    Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

  • Associated Press

    Judge dismisses Chemours lawsuit against DuPont

    A Delaware judge has granted the DuPont Co.'s request to dismiss a lawsuit alleging that it massively downplayed the cost of environmental liabilities imposed on spinoff company Chemours. Vice Chancellor Sam Glasscock III ruled Monday that he has no jurisdiction to hear the case because the separation agreement between the companies clearly states that all disputes arising from the spinoff are subject to binding arbitration. DuPont issued a statement saying it was pleased with the ruling and would take steps to enforce its rights under the separation agreement.

  • Here's Why You Should Hold Onto Chemours (CC) Stock Now
    Zacks

    Here's Why You Should Hold Onto Chemours (CC) Stock Now

    Chemours (CC) should gain from its actions to drive Opteon adoption and boost productivity across its business segments in 2020.

  • Chemours (CC) Down 34.3% Since Last Earnings Report: Can It Rebound?
    Zacks

    Chemours (CC) Down 34.3% Since Last Earnings Report: Can It Rebound?

    Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Chemours (CC) Inaugurates State-of-the-art Innovation Center
    Zacks

    Chemours (CC) Inaugurates State-of-the-art Innovation Center

    Chemours' (CC) new facility is one of Delaware's biggest R&D centers and one of the largest R&D facilities in the chemical industry.

  • Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q4
    Zacks

    Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q4

    Lower volumes and prices in Titanium Technologies and Fluoroproducts units hurt Chemours' (CC) Q4 sales.

  • Implied Volatility Surging for Chemours (CC) Stock Options
    Zacks

    Implied Volatility Surging for Chemours (CC) Stock Options

    Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

  • Associated Press

    Chemours: 4Q Earnings Snapshot

    WILMINGTON, Del. (AP) _ Chemours Co. (CC) on Thursday reported a fourth-quarter loss of $317 million, after reporting a profit in the same period a year earlier. Earnings, adjusted for non-recurring costs and restructuring costs, were 56 cents per share. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 43 cents per share.

  • Chemours (CC) to Post Q4 Earnings: What's in the Cards?
    Zacks

    Chemours (CC) to Post Q4 Earnings: What's in the Cards?

    Our proven model does not predict an earnings beat for Chemours (CC) this season.

  • Chemours' Opteon XP10 Refrigerants Chosen by Sharc Energy
    Zacks

    Chemours' Opteon XP10 Refrigerants Chosen by Sharc Energy

    Chemours (CC) anticipates the collaboration to help Sharc Energy engage in refrigerant solutions that are more environmentally sustainable.

  • GlobeNewswire

    Sharc Energy Selects Opteon™ XP10 (R-513A) Refrigerants for Next Generation PIRANHA™

    SHARC selected The Chemours Company FC, LLC (“Chemours”) and its Opteon™ XP10 (R-513A), because it offers a non-ozone depleting, low GWP hydrofluoro-olefin (“HFO”) based refrigerant developed with a 56% reduction to replace R-134a in positive displacement, direct expansion, medium-temperature commercial and industrial fixed speed systems, chillers, and heat pumps (HP) such as the PIRANHA™ while providing improved energy efficiency, similar capacity, and excellent design compatibility.

  • Associated Press

    Judge halts arbitration in Chemours-DuPont dispute

    A Delaware judge has temporarily halted arbitration between the DuPont Co. and Chemours as he weighs DuPont's request to dismiss a lawsuit claiming that it massively downplayed the cost environmental liabilities imposed on Chemours. The case centers on theliabilities Chemours was saddled with after DuPont spun off its former performance chemicals unit in 2015. The judge's granted Chemours' request to pause the arbitration on Thursday, one day after he heard arguments on DuPont's dismissal motion.

  • Associated Press

    DuPont seeks to toss Chemours environmental liabilities suit

    The DuPont Co. is asking a Delaware judge to dismiss a lawsuit claiming that it massively downplayed the cost of environmental liabilities that Chemours would be saddled with when DuPont spun off its former performance chemicals unit. An attorney for DuPont argued Wednesday that the lawsuit must be dismissed because the separation agreement with Chemours mandates that any disputes arising from the 2015 spinoff must be resolved through private arbitration. DuPont attorney Robert Saunders also rejected the notion that DuPont deliberately set up Chemours to fail by shifting hundreds of millions of dollars in environmental liabilities to it.

  • GlobeNewswire

    3-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Securities

    SAN FRANCISCO, Dec. 06, 2019 -- Hagens Berman urges The Chemours Company (NYSE: CC) investors who have suffered significant losses on Chemours common stock, options and/or.

  • GlobeNewswire

    DEADLINE ALERT - The Chemours Company (CC) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 9, 2019

    Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against The Chemours Company (“Chemours” or the “Company”) (CC) and certain of its officers, on behalf of shareholders who purchased Chemours securities between February 16, 2017 and August 1, 2019 (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws. The Complaint alleges that, throughout the Class Period, Defendants misled investors by representing that Chemours had appropriately accounted and accrued reserves for its environmental liabilities, that the possibility of costs exceeding accrued amounts was "remote," and that, in any event, additional costs would not be material.

  • GlobeNewswire

    Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against The Chemours Company

    If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. In July 2015, Chemours became public via a spinoff of the Performance Chemicals division of E.I. du Pont de Nemours and Company (“DuPont”).

  • GlobeNewswire

    SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ADTN, CC, PRU INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Dec. 04, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.